Literature DB >> 29068586

Systemic sclerosis sine scleroderma.

Eugeniusz J Kucharz1, Magdalena Kopeć-Mędrek1.   

Abstract

Systemic sclerosis is a rare generalized disease with scleroderma, i.e. skin thickening as one of the most common symptoms. The disease has 2 main subsets, diffuse and limited forms. The subset known as systemic sclerosis sine scleroderma (ssSSc) is a very rare subset characterized by the total or partial absence of cutaneous manifestations of systemic sclerosis with the occurrence of internal organ involvement and serologic abnormalities. The classification of ssSSc into 3 groups was proposed. Type I (complete) is characterized by the lack of any cutaneous changes typical for the disease at least until systemic sclerosis-related insufficiency of any internal organ occurs. Type II (incomplete) is characterized by the absence of sclerodactyly, but other cutaneous involvements (e.g. calcifications, telangiectasies, pitting scars) can be found. Type III (delayed) is characterized by clinical internal organ involvement typical for systemic sclerosis that has appeared before skin changes (complete or incomplete). In general, the demographic and clinical characteristics of the ssSSc patients suggest that they are similar to those with diffuse or limited form of the disease. Diagnosis of ssSSc still remains difficult and this disease form should be considered in all cases of unexplained fibrotic involvement of the internal organs.

Entities:  

Keywords:  internal organ fibrosis; sclerodactyly; scleroderma; systemic sclerosis

Mesh:

Year:  2017        PMID: 29068586     DOI: 10.17219/acem/64334

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  12 in total

1.  Cultural adaptation, translation and validation of Cochin Hand Function Scale and evaluation of hand dysfunction in systemic sclerosis.

Authors:  Devender Bairwa; Chengappa G Kavadichanda; M B Adarsh; Aishwarya Gopal; Vir Singh Negi
Journal:  Clin Rheumatol       Date:  2020-10-15       Impact factor: 2.980

Review 2.  Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis.

Authors:  George Hung; Valentina Mercurio; Steven Hsu; Stephen C Mathai; Ami A Shah; Monica Mukherjee
Journal:  Curr Rheumatol Rep       Date:  2019-12-07       Impact factor: 4.592

Review 3.  Metabolic Regulation of Fibroblast Activation and Proliferation during Organ Fibrosis.

Authors:  Sudan Wang; Yan Liang; Chunsun Dai
Journal:  Kidney Dis (Basel)       Date:  2022-03-03

4.  Trends in Demographics, Hospitalization Outcomes, Comorbidities, and Mortality Risk among Systemic Sclerosis Patients.

Authors:  Oluyemisi Amoda; Virendrasinh Ravat; Sorabh Datta; Bipin Saroha; Rikinkumar S Patel
Journal:  Cureus       Date:  2018-05-14

5.  Scleroderma Renal Crisis in a Systemic Sclerosis With Anti-PM/Scl Antibodies.

Authors:  Marine Jacquier; Christiane Mousson; Jean-Michel Rebibou; Daniela Lakomy; Stéphanie François; Laurent Martin; Mathilde Funes De La Vega; Mathieu Legendre
Journal:  Kidney Int Rep       Date:  2019-07-10

6.  A 45-Year-Old Man with Scleroderma Renal Crisis Associated with a History of Systemic Sclerosis Sine Scleroderma.

Authors:  Panupong Hansrivijit; Kelechi F Omeonu; Halimat O Lawal; Mounika Gangireddy; Kinjal P Gadhiya; Ravinder S Dhatt
Journal:  Am J Case Rep       Date:  2020-11-24

Review 7.  Ocular manifestations in patients with systemic sclerosis.

Authors:  Małgorzata Kozikowska; Wojciech Luboń; Eugeniusz J Kucharz; Ewa Mrukwa-Kominek
Journal:  Reumatologia       Date:  2020-12-23

Review 8.  Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification.

Authors:  Changyi Yang; Shunli Tang; Dingxian Zhu; Yingguo Ding; Jianjun Qiao
Journal:  Front Med (Lausanne)       Date:  2020-11-19

9.  Chromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis.

Authors:  Qian Liu; Lisa C Zaba; Ansuman T Satpathy; Michelle Longmire; Wen Zhang; Kun Li; Jeffrey Granja; Chuang Guo; Jun Lin; Rui Li; Karen Tolentino; Gabriela Kania; Oliver Distler; David Fiorentino; Lorinda Chung; Kun Qu; Howard Y Chang
Journal:  Nat Commun       Date:  2020-11-17       Impact factor: 14.919

10.  IFN-γ+ IL-17+ Th17 cells regulate fibrosis through secreting IL-21 in systemic scleroderma.

Authors:  Xiaojing Xing; Anqi Li; Hong Tan; Yong Zhou
Journal:  J Cell Mol Med       Date:  2020-11-06       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.